The beneficial effect of palliative resection in metastatic colorectal cancer

British Journal of Cancer

Volumn 108, Issue 7, 2013, Pages 1425-1431

  Kim, T Y ^a,a,b,b,c   Park, J H ^a   Lee, K H ^a,b   Han, S W ^a,b   Oh, D Y ^a,b   Im, S A ^a,b   Kang, G H ^a   Chie, E K ^a   Ha, S W ^a   Jeong, S Y ^a   Park, K J ^a   Park, J G ^a  

^a Seoul National University Hospital   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

^c Seoul National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; COLORECTAL CANCER; FEMALE; HUMAN; LIVER METASTASIS; LUNG METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS RESECTION; OVERALL SURVIVAL; PALLIATIVE THERAPY; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; COMBINED MODALITY THERAPY; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; PALLIATIVE CARE; PROGNOSIS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84876496714     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2013.94     Document Type: Article

References (23)

1. Ballantyne GH, Quin J (1993) Surgical treatment of liver metastases in patients with colorectal cancer. Cancer 71(12 Suppl): 4252-4266. (Pubitemid 23169104)
2. Connors Jr. AF, Speroff T, Dawson NV, Thomas C, Harrell Jr FE, Wagner D, Desbiens N, Goldman L, Wu AW, Califf RM, Fulkerson Jr WJ, Vidaillet H, Broste S, Bellamy P, Lynn J, Knaus WA (1996) The effectiveness of right heart catheterization in the initial care of critically ill patients. SUPPORT Investigators. JAMA 276(11): 889-897. (Pubitemid 26301608)
3. Cunningham D, Humblet Y, Siena S, Khayat D, Bleiberg H, Santoro A, Bets D, Mueser M, Harstrick A, Verslype C, Chau I, Van Cutsem E (2004) Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer. N Engl J Med 351(4): 337-345. (Pubitemid 38944402)
4. Earle CC, Tsai JS, Gelber RD, Weinstein MC, Neumann PJ, Weeks JC (2001) Effectiveness of chemotherapy for advanced lung cancer in the elderly: instrumental variable and propensity analysis. J Clin Oncol 19(4): 1064-1070. (Pubitemid 32176282)
5. Erroi F, Scarpa M, Angriman I, Cecchetto A, Pasetto L, Mollica E, Bettiol M, Ruffolo C, Polese L, Cillo U, D'Amico DF (2007) Ovarian metastasis from colorectal cancer: Prognostic value of radical oophorectomy. J Surg Oncol 96(2): 113-117. (Pubitemid 47264813)
6. Galizia G, Lieto E, Orditura M, Castellano P, Imperatore V, Pinto M, Zamboli A (2008) First-line chemotherapy vs bowel tumor resection plus chemotherapy for patients with unresectable synchronous colorectal hepatic metastases. Arch Surg 143(4): 352-358; discussion 358. (Pubitemid 351574853)
7. Grothey A, Sargent D, Goldberg RM, Schmoll H-J (2004) Survival of patients with advanced colorectal cancer improves with the availability of fluorouracil-leucovorin, irinotecan, and oxaliplatin in the course of treatment. J Clin Oncol 22(7): 1209-1214. (Pubitemid 41079833)
8. Headrick JR, Miller DL, Nagorney DM, Allen MS, Deschamps C, Trastek VF, Pairolero PC (2001) Surgical treatment of hepatic and pulmonary metastases from colon cancer. Ann Thorac Surg 71(3): 975-980. (Pubitemid 32210413)
9. Ho TW, Mack LA, Temple WJ (2011) Operative salvage for retroperitoneal nodal recurrence in colorectal cancer: a systematic review. Ann Surg Oncol 18(3): 697-703.
10. Hurwitz H, Fehrenbacher L, Novotny W, Cartwright T, Hainsworth J, Heim W, Berlin J, Baron A, Griffing S, Holmgren E, Ferrara N, Fyfe G, Rogers B, Ross R, Kabbinavar F (2004) Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 350(23): 2335-2342. (Pubitemid 38702844)
11. Iwashyna TJ, Lamont EB (2002) Effectiveness of adjuvant fluorouracil in clinical practice: a population-based cohort study of elderly patients with stage iii colon cancer. J Clin Oncol 20(19): 3992-3998.
12. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ (2009) Cancer Statistics, 2009. CA Cancer J Clin 59(4): 225-249.
13. Liu SKM, Church JM, Lavery IC, Fazio VW (1997) Operation in patients with incurable colon cancer-Is it worthwhile? Dis Colon Rectum 40(1): 11-14. (Pubitemid 27056392)
14. Mahteme H, Hansson J, Berglund A, Pahlman L, Glimelius B, Nygren P, Graf W (2004) Improved survival in patients with peritoneal metastases from colorectal cancer: a preliminary study. Br J Cancer 90(2): 403-407. (Pubitemid 38250636)
15. McCormick CC, Giuntoli 2nd RL, Gardner GJ, Schulick RD, Judson K, Ronnett BM, Vang R, Bristow RE (2007) The role of cytoreductive surgery for colon cancer metastatic to the ovary. Gynecol Oncol 105(3): 791-795. (Pubitemid 46745305)
16. Miller BE, Pittman B, Wan JY, Fleming M (1997) Colon cancer with metastasis to the ovary at time of initial diagnosis. Gynecol Oncol 66(3): 368-371. (Pubitemid 27388125)
17. Mourra N, Hoeffel C, Duvillard P, Guettier C, Flejou JF, Tiret E (2008) Adrenalectomy for clinically isolated metastasis from colorectal carcinoma: report of eight cases. Dis Colon Rectum 51(12): 1846-1849.
18. Rayson D, Bouttell E, Whiston F, Stitt L (2000) Outcome after ovarian/adnexal metastectomy in metastatic colorectal carcinoma. J Surg Oncol 75(3): 186-192.
19. Regnard J-F, Grunenwald D, Spaggiari L, Girard P, Elias D, Ducreux M, Baldeyrou P, Levasseur P (1998) Surgical treatment of hepatic and pulmonary metastases from colorectal cancers. Ann Thorac Surg 66(1): 214-218. (Pubitemid 28389261)
20. Rosen SA, Buell JF, Yoshida A, Kazsuba S, Hurst R, Michelassi F, Millis JM, Posner MC (2000) Initial presentation with stage IV colorectal cancer: How aggressive should we be? Arch Surg 135(5): 530-534.
21. Ruo L, Gougoutas C, Paty PB, Guillem JG, Cohen AM, Wong WD (2003) Elective bowel resection for incurable stage IV colorectal cancer: prognostic variables for asymptomatic patients. J Am Coll Surg 196(5): 722-728. (Pubitemid 36560202)
22. Scoggins C, Meszoely I, Blanke C, Beauchamp R, Leach S (1999) Nonoperative management of primary colorectal cancer in patients with stage IV disease. Ann Surg Oncol 6(7): 651-657.
23. Sobrero AF, Maurel J, Fehrenbacher L, Scheithauer W, Abubakr YA, Lutz MP, Vega-Villegas ME, Eng C, Steinhauer EU, Prausova J, Lenz H-J, Borg C, Middleton G, Kröning H, Luppi G, Kisker O, Zubel A, Langer C, Kopit J, Burris HA (2008) EPIC: Phase III trial of cetuximab plus irinotecan after fluoropyrimidine and oxaliplatin failure in patients with metastatic colorectal cancer. J Clin Oncol 26(14): 2311-2319.